DiaSorin Releases Educational Webinar Exploring the Association of Biotin Ingestion with Performance of Hormone and Nonhormone Assays

Share Article

LabRoots will host this webinar October 11, in which attendees will learn why the continuing trend of high dose biotin use may be a game changer of the clinical diagnostic industry

Danni Li, PhD, DABCC Director of Clinical Chemistry, University of Minnesota Medical Center, and Assistant Professor of Laboratory Medicine and Pathology, University of Minnesota

High dose of biotin may cause interference with many routine clinical immunoassays and inaccurate results of some of the tests such as cardiac troponin has serious clinical complications. There is an increasing trend of high dose biotin supplement use in the US population, although the exact prevalence is still unknown.

High dose of biotin supplement use may continue to increase due to its health and medical benefits and disrupt the diagnostic industry so some of the tests with serious clinical complications should be resigned to avoid biotin interference. Through this webinar, the speaker will explain why more research is needed to understand the nutritional and therapeutic values of biotin.

This webinar, which is sponsored by DiaSorin, will review mechanisms and factors that determine high dose biotin interference with lab tests. They will gain a better understanding of the increasing trend of high dose biotin use and health and medical benefits. The speaker for this event will be Dr. Danni Li, the Director of Clinical Chemistry at the University of Minnesota Medical Center and an Assistant Professor of Laboratory Medicine and Pathology at the University of Minnesota.

Li earned a Bachelor of Science in Chemistry from Zhejiang University in Hangzhou, China, then went on to earn a doctorate in Analytical Chemistry at the University of Minnesota. She has active research interests in high dose biotin supplement use prevalence in the United States and its impact on public health. In addition, Li has developed her independent research program in applying proteomics and lipidomics to discover plasma biomarkers in Alzheimer's disease.

LabRoots will host this webinar on October 11, 2018, beginning at 9 a.m. PDT. To learn more about this event, the continuing education credits offered, or to register for free, click here.

About DiaSorin Group
Headquartered in Italy and listed in the FTSE Mid Cap Index, DiaSorin is a global leader in the In Vitro Diagnostic (IVD) field. For over 40 years the Company has been developing, producing and marketing reagent kits for IVD worldwide. Through constant investments in research and development, and using its own distinctive expertise in the field of immunodiagnostics to deliver a high level of innovation, DiaSorin offers today the broadest range of specialty tests available in the immunodiagnostics market and new tests in the molecular diagnostics markets, which identify DiaSorin Group as the IVD “Diagnostics Specialist.”

About LabRoots
LabRoots is the leading scientific social networking website, offering top scientific trending news and premier educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning. We have become a primary source for trending scientific news, webinars, virtual conferences and more. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, LabRoots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events. Join for free and become part of the largest scientific learning community in the world.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Karen Sorenson
LabRoots, Inc.
+1 (619) 861-0590
Email >
Visit website